There are 2789 resources available
573P - Panorama of genomic RET alterations (GA) in the major subtypes of thyroid carcinomas (TC)
Presenter: Daniel Bowles
Session: ePoster Display
574P - Clinical impact of the GAPP score and SDHB negativity in patients with pheochromocytoma/paraganglioma
Presenter: Akihiro Ohmoto
Session: ePoster Display
575TiP - Cabozantinib plus atezolizumab in advanced and progressive neoplasms of the endocrine system: A multicohort phase II trial (CABATEN trial / GETNE-T1914)
Presenter: Enrique Grande
Session: ePoster Display
581P - Patient (pt) reported pain in men with metastatic castration-resistant prostate cancer (mCRPC) receiving talazoparib (TALA): TALAPRO-1
Presenter: Fred Saad
Session: ePoster Display
582P - Health-related quality of life (HRQoL) at final analysis of the GALAHAD study of niraparib in patients with metastatic castration-resistant prostate cancer (mCRPC) and DNA repair defects (DRD)
Presenter: Matthew Smith
Session: ePoster Display
545P - First-in-human (FIH) study of E7130 in patients (pts) with advanced solid tumors: Primary result of dose-escalation part
Presenter: Toshihiko Doi
Session: ePoster Display
528P - Discovery of ZN-d5, a potent BCL-2 inhibitor with improved selectivity for BCL-2
Presenter: Joseph Pinchman
Session: ePoster Display